Leadership

Barry Ressler

Mr. Ressler is the co-founder and Chief Executive Officer of the Interplanetary Space Sciences (IPSSCI), www.ipssci.com. IPSSCI and its affiliate companies and partners are space qualifying their earth-based science and technology products and systems to deploy for 21st Century Lunar and Interplanetary Humans in Space exploration, colonization and tourism.

Mr. Ressler also founded STAR Associates, Inc., (www.star-assoc.com) in 1994, now in its 28th , to provide corporate, technology and product development, IP analysis, market landscape assessment, competitive strategies, and financial transaction advisory services to public and private companies in emerging technologies.

Mr. Ressler is a co-founder and Chairman of the Board of EP Therapeutics, Inc. a bio-pharmaceutical company engaged in the development of a revolutionary new class of therapeutics, a safer, alternative treatment for human cancers by eliminating the need for chemotherapy or radiation treatment protocols. EP Therapeutics is an affiliate company of Interplanetary Space Sciences (IPSSCI).

From 1994 to 2018, Mr. Ressler co-founded Triton Thalassic Technologies, Inc. (T3i) and served as the CEO and Chairman . The company engaged in the non-chemical pathogen inactivation of blood products; photo-activation of therapeutic compounds and the treatment and control of micro-organism contaminated fluids for the industrial, food packaging, and beverage industries, and licensed the technology to major pharmaceutical companies.

From 1975 to December 1993, he served as CEO and Chairman of Universal Voltronics Corporation (UVC), a public company (NASDAQ and AMEX) that developed high-voltage Pulse Power products for scientific research, SDIO defense, alternative energy sources, medical diagnostics/therapeutics and for industrial applications. In March 1990, UVC became a public subsidiary of Thermo Electron Corp, now Thermo Fisher Scientific.

Mr. Ressler serves on the Board of Directors of Forever Identity Inc. (https://foreveridentity.com/articles/), a Delaware Corporation that has developed and patented three distinct products to create and preserve identity, biography, memory, personality, and physical aspects to allow interaction with future generations. FOREVER Identity combines artificial intelligence, decision, ethical and moral engines, semantic and ontology experts to provide cutting-edge products space industry diagnostics, historic figure preservation. Education (STEM) and telemedicine applications. Forever Identity is an affiliate company of Interplanetary Space Sciences (IPSSCI).

Mr. Ressler served on the Board of Directors of StemCyte Inc., a global company engaged in Public and Private Umbilical Cord Blood Banking operations and advanced stem cell therapeutics for spinal cord injury, stroke, diabetes, thalassemia, and Leukemia.

From 1994 to 2007 Mr. Ressler served as a member of the Board of Directors and Chairman of the of Corporate Governance Committee of JMAR Technologies Inc. (NASDAQ JMAR) the originator of Collimated Plasma Lithography and products for the public and private sectors based on its proprietary “Britelight(TM)” laser light source and homeland security, for the detection of explosives, toxic gases (nerve and blister agents), and pollutant detection.

From 1996 to 2004 Mr. Ressler has also served as a member of the Nauticos Corp. Sciences Business and Technology Advisory Board. Nauticos developed advanced side scan sonar, ROV and research protocols used in the discovery of historic and contemporary sunken vessels.

Mr. Ressler has also served on the scientific advisory boards of the University of Connecticut Biotechnology Center, Modal Technology Corp (www.modal.net) and RDX (www.reactionDynamics.space). He has been an invited speaker to the Parenteral Drug Association, the FDA for Aseptic and Advanced Sterilization Technologies, the United Nations conference for the Use of Artificial Intelligence for Medicine and is a member of the Global AI Pioneers Strategy Organization.

Mr. Ressler holds 7 patents in the field of monochromatic UV sterilization of industrial fluids, blood products, injectables, ophthalmic healthcare packaged products and Parenteral Drug Delivery IV/Renal Bag technology and food/beverage
process applications.

Dr. Steve Diamond

Steve is a board certified licensed physician, a medical examiner, forensic pathologist and medical entrepreneur. Steve currently serves as a senior executive for various medical and research organizations. He is Director of Laboratories at Hunterdon Medical Center in Flemington, NJ, Medical Director at LabCorp National Clinical Trials Laboratory and Tandem Laboratories, and Associate Director, Miller-Keystone Memorial Blood Bank. In addition, Steve is the Medical Examiner for Hunterdon County in New Jersey, USA.

Steve received his Doctorate of Osteopathic Medicine (DO) from Mid-Western University, Chicago, IL and completed residency training in pathology at the University of Wisconsin, Philadelphia Naval Hospital and Thomas Jefferson University. He is board certified in Anatomic and Clinical Pathology, Hematopathology, and by the American Board of Medicolegal Death Investigators.

Steve received his MBA from the Wharton School of Business at the University of Pennsylvania. His business experience includes:

Developer and general partner of a physician-owned MRI center involving limited partners who were neurologists, neurosurgeons and orthopedic surgeons at Muhlenberg Hospital, Bethlehem, PA;
CEO, Medinfocare –a medical software company that provided medical triage information. The company was a Ben Franklin Technology Grant awardee;
CEO, MyTravelMate –a portable synoptic medical chart with travel emergency call capability. Dr. Diamond holds the patent for this technology;
Lead developer, Telepathology with a national pathology laboratory to export pathology slides to a foreign venue; and
Co-founder and Board Member, EP Therapeutics, a biotechnology company focusing on cancer treatment.

As a past member of the Management Resource Committee of the College of American Pathologists, Steve developed the Virtual Business College for pathologists. He also taught graduate courses in the Business of Medicine at Lehigh University’s College of Business. He is a member of the College of American Pathologists, American Board of Medicolegal Death Investigators and the Medical Society of Pennsylvania.

Gordon Roesler

Autonomous Space Robots CEO of Robots in Space

Dr. Roesler is a scientist, team-builder, technology manager and innovator who has specialized in creating change in engineered systems through innovative research programs. He has conceived, initiated and managed numerous programs involving extreme performance in challenging environments, including space systems, robotic naval vehicles, and sensor systems. Key technology leadership accomplishments include DARPA’s space robotic servicing vehicle, an automated design approach for space architectures, ocean energy concepts, acoustics, and marine systems. His work has been featured in widely read journals and has influenced major defense programs. He is a recipient of numerous civilian and military awards.

Thais Russomano

Professor THAIS RUSSOMANO MD MSc PhD

An organized, detail-oriented, and conscientious self-starter, with more than 30 years of experience in Space Life Science, Aerospace Medicine, Biomedical Engineeringand Telehealth. An effective leader, skilled in motivating and enlisting the support of colleagues and team members in alignment with project and organizational goals, demonstrated by the establishment and coordination of the Microgravity Centre, PUCRS, Brazil, an internationally recognized and pioneer Space Life Sciences Research Centre in Latin America.

Able to strategize and prioritize effectively to accomplish multiple tasks and work successfully in nationaland international scenarios. Understanding of the importance of academic/commercial collaboration and partnerships in developing innovative products and processes for the market. Skilled in academic course creation and delivery at community, graduate and postgraduate levels.

Current Positions Held

Founder & Director, InnovaSpaceLtd, UK
Scientific Director of Astrobionix, UK
Co-Founder, Director & Chief Medical Officer, International SpaceMedicineConsortium Inc., USA
Visiting Professor, Centre for Human and Applied Physiology (CHAPS), School of Basic & Medical Biosciences, Faculty of LifeSciences & Medicine, King’s College London
Affiliated Member of theKing’s Brazil-Institute
Visiting Professor at UFCSPA, Brazil
Professor, School of Medicine, Lisbon University, Portugal
Invited AssociateProfessor, Carol Davila University of Medicine & Pharmacy, Romania
Guest lecturer ViCCA Master’s Course teaching Space& Design module, Alto University, Finland
Guest lecturer at theMaster’s Course in Medical Informatics, Deggendorf Institute of Technology, Germany
Consultant Skolkovo Foundation, Moscow, Russia
Member of the iB Hubs Global Mentor Community, eHealth projects, India
Brazilian representativefor the ISO/TC 20/SC 14/WG 6, Spacesystems and operations(Manned space flight)
Mentor of theSpace4Women, UNOOSA, UN (2019-2020)
International Academy of Astronautics, Board of Trustees & other scientific and educational committees

Summary

30+ years experience in Aerospace Medicine, Human Physiology, Biomedical Engineering, Telemedicine & eHealth
Founded & Coordinated for 18 years the Microgravity Centre (MicroG), PUCRS, Brazil
Special interest & active participation in research/committees into Manned Space Flight and Space Tourism
Development of Microgravity/Hypogravity & Hypergravity simulation research projects
Development of a n international MicroG network of Space focused research teams
Educational Space lectures for the Brazilian Space Agency, Universities, Schools and general public
Biomedical research & development, project coordination, management & liaison
Inter-, multi-, transdisciplinary experience in developing and conducting national & international eHealth projects
Invited participant, Rockefeller Foundation sponsored National eHealth Policies conference, Bellagio 2008
Co-founder/Co-Coordinator of the Student Committee of the International Society for Telemedicine & eHealth
Peer reviewer for 5 scientific journals in the areas of Telemedicine, eHealth and Aerospace Sciences
Multidisciplinary teaching at both undergraduate& postgraduate level
Extensive supervision of PhD& MSc thesis and BSc final projects at PUCRS & King’s College London
Numerous publications in peer reviewed journals and Chapters in Books
Publication of 6 books in the areas of Astronomy, Space Life Sciences, & Aerospace Biomedical Engineering
Holder of 7 patents: Products and processes related to Space Life Sciences and Aerospace Biomedical Engineering Research areas include: telemedicine and eHealth projects; digital health, VR, AR and AI, microgravity, hypogravity and hypergravity simulations; parabolic flight campaigns with the European Space Agency; hyperbaric and hypobaric chamber studies; tests in human centrifuges, Barany’s chair, flight simulators, lower body positive pressure and negative pressure boxes, and positive pressure chambers, among others.

Educational Background

2006	– 2007	Post-Doctoral in Space Life Science, King’s College London, England, UK
2000	– 2009	Visiting Research Fellow – Department of Aerospace Medicine and Human Applied Physiology, King’s College London, UK
1994	– 1998	PhD in Respiratory SpacePhysiology, King’s College London, England, UK
1991	– 1995	MD in Emergency Rooms, Intensive Care Units and Ambulance Services, in thePorto Alegre region
1989	– 1991	Master’s Degree Program in Aerospace Medicine (GPA = 3.94/4.0), Wright State University, Ohio, USA
1985	– 1989	Internal Medicine Residency Program, Clinical Hospital of Porto Alegre, RS, Brazil. Chief Resident(1988) and Senior Resident (1989) in Internal Medicine
1980	– 1985	School of Medicine of the Federal University of Pelotas, RS, Brazil

Research/Teaching & Employment Positions

2020 – Professor at the School of Medicine, University of Lisbon, Portugal & Project Manager of CEMA
2020 – Invited professor at Carol Davila University of Medicine and Pharmacy, Romania
2020 – Visiting Senior Lecturer, CHAPS, King’s College, London
2019 – Professor (collaborator) UFCSPA & co-founder e coordinator of Space & Extreme Environment
- Research Center, Brazil
2018 – Founder & Director, InnovaSpaceLtd, London UK
2017 – Guest Lecturer at Deggendorf Institute of Technology, Germany, delivering eHealth modules
2016 – 2019 International RelationsDirector, HuSCO, Human Spaceflight Capitalization Office, London, UK
2015 – Co-Founder, Corporate Director & Chief Medical Officer, International Space Medicine Consortium Inc. (www.I SMCInc.com)
2014 – Scientific consultant, Skolkovo Foundation, Moscow, Russia
2013 – Guest Lecturer at Alto University, Finland delivering Space & Design modules
2009 – 2009 Consultant – Wyle Laboratories GmbH, Cologne, Germany – Earlobe Arterialized Blood Collector Study
2001 – 2017 Supervisor – MSc Dissertations – Biomedical Engineering Master’s Degree Program, School of Engineering, PUCRS, Porto Alegre, RS, Brazil
2009 – 2020 Deputy Course Director/Senior Lecturer, CHAPS, King’s College, London
2000 – 2009 Visiting Research Fellow – Department of Aerospace Medicine and Human Applied Physiology, King’s College London
1999 – 2017 Coordinator of theMicrogravity Centre, PUCRS, Porto Alegre, RS, Brazil
1998 – 2017 Professor – Biomedical Engineering Master’s DegreeProgram – School of Electrical Engineering, PUCRS, Porto Alegre, RS, Brazil
1998 – 2017 Professor – Institute of Aeronautical Sciences, PUCRS, Porto Alegre, RS, Brazil
1998 – 2017 Professor – Department of Internal Medicine, School of Medicine, PUCRS, Porto Alegre, RS, Brazil
1997 – Guest Scientist – Institute of Aerospace Medicine, German Space Agency – DLR, Cologne, Germany
1993 – 1998 Assistant Professor – Department of Internal Medicine, School of Medicine, PUCRS, Porto Alegre, RS, Brazil

Some Projects Developed Under My Coordination

Development and Validation of:
First all-Brazilian Heart Defibrillator; Normobaric Hypoxia Chamber; Lower Body Negative Pressure Box and Lower Body Positive Pressure Box; Human Powered Small Centrifuge; Small centrifuge for the study of effects of hyperG on plants; Tilt Table for Microgravity Simulation; Earlobe Blood Collector for use in Microgravity; 3D Clinostat for the Study of Cells in Microgravity Simulation; Barany’s Chair for the Study of the Vestibular System; Small hypobaric chamber to study the effects of pressure changes on medication; Individual portable dark chambers for pilot education/training.
Hypergravity simulation – Small centrifuge for plants and cells & human powered centrifuge for human studies and training
Evaluation of Cardiopulmonary Resuscitation Procedures in Microgravity (Parabolic Flight) and Hypogravity simulation
Tele-transmission of surgical procedures
Tele-education via international video conferences
Tele-medical assistance to remote areas including projects in: Tele-ECG, Tele-dermatology, Tele-pathology, Tele- odontology, Tele-toxicology, Tele-nutrition, Tele-pharmacy, Tele-physiotherapy, Tele-psychiatry and Tele-radiology
eHealth for primary care attention
eHealth for Indian tribes in the Amazon, Brazil

Dr. Thomas Chen

Chief Scientist

Received his Ph.D. degree in Genetics from the University of Alberta, Canada, in 1973. He has served as a post-doctoral fellow at Queen’s University, Canada, Assistant and Professor at McMaster University, Canada and professor at the University of Maryland Biotechnology Institute and University of Connecticut. From 1986-1995, Dr. Chen also served as Associate Director for research and faculty development at the Center of Marine Biotechnology, UMBI and Associate Provost of UMBI. In 1995, Professor Chen was recruited by the University of Connecticut to head the Biotechnology Center and also serve as a professor at the Department of Molecular and Cell Biology. He stepped down from the directorship of the Biotechnology Center in July 2002 and continues to serve as a professor in the Department of Molecular & Cell Biology.

During the past 30 years, Professor Chen has made numerous important contributions in the areas of molecular endocrinology and biotechnology and has recruited in excess of 10 million dollars of research funding to support his scientific pursuits. He has published more than 138 scientific papers in peer-reviewed international journals. In addition, he also holds three patents including the E-P technology.

Doris A. Taylor, PhD, FAHA, FACC, FESC

Director – Advanced Regenerative Medical Science

Dr Doris Taylor, CEO RegenMedix Consulting LLC, is a dynamic scientist who has made field- changing innovations in regenerative medicine, stem cell profiling, and tissue engineering.

Based on her exceptional ability to reduce these complex topics to simple messages, she is also a highly sought after motivational and keynote speaker nationally and internationally at scientific, corporate, and medical conferences. She currently serves as a consultant in both the regenerative medicine and biotechnology space for government, academia, and industry.

Dr. Taylor helped create the field of cardiovascular regenerative medicine and is widely regarded as a major thought-leader in the field; her mechanistic insights and effective approaches to cardiac repair and replacement are well established and include a number of firsts. At Duke University Medical Center in 1998, she described the first functional repair of injured heart with cells – helping establish cardiovascular regenerative medicine. In 2000 recognizing that cells were heterogeneous and would persist in patients, she began to link individual cardiovascular cell product profiles to patient health and clinical trial outcome – building a capacity to reduce trial size and ask cutting edge questions about the roles of biologic sex, age, and race/ethnicity in cardiovascular regenerative medicine. In 2008, Taylor developed a whole-organ perfusion decellularization method that yielded an acellular solid organ scaffold with vasculature – transforming tissue and organ engineering possibilities. This was so revolutionary it was recognized as one of the “Top 10 Research Advances” by the American Heart Association and Taylor was nominated as one of “100 most influential people in the world” by Time magazine.

In 2009, Taylor co-founded Miromatrix Medical Inc. to commercialize decellularized/ recellularized products. Taylor holds 4 US and 28 international related patents and was recently elected as a senior member of the National Academy of Inventors. She continues to create academic-industry partnerships designed to build regenerative medicine solutions for patients.

Having served on the FDA Cell and Gene Therapy Advisory Panel, the Alliance for Regenerative Medicine Board/Executive Committee, and patient advocacy groups Taylor recognizes the critical importance of communication among scientists, sponsors, patients and regulators. She has been/is involved (inter)nationally on working committees for ESC, NHLBI, AHA, ACC, AABB, FACT, ISHLT, TERMIS, and the Standards Coordinating Body. She co-chairs the Advanced Regenerative Manufacturing Institute (ARMI) Tissue Manufacturing working group, serves on

the ARMI Leadership Advisory Council and is a member of the NIH-wide Regenerative Medicine Information Catalyst that is responsible for designing common data elements for basic, preclinical, and clinical regenerative medicine research funded under the 21st Century Cures Act.

Dr Taylor and her work has been featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, Associated Press, National Public Radio, and most worldwide media outlets. In 2019, she became a Senior member of the National Academy of Inventors.

Academic Positions

Texas Heart Institute (2012- March 2020):

Director, Regenerative Medicine Research, Texas Heart Institute (2012- 2020)
Director, Center for Cell and Organ Biotechnology, Texas A&M University and Texas Heart Institute (2013-2020)
Director, Biorepository and Sample Profiling Core, NHLBI Cardiovascular Cell Therapy Research Network (CCTRN) and Cardiothoracic Surgery Network (CTSN) (2006-2020)

University of Minnesota Medical School (2003-2012):

Medtronic Bakken Professor of Integrative Biology and Physiology
Professor, Department of Medicine
Director, Center for Cardiovascular Repair

Duke University School of Medicine (1991-2003):

Assistant to Associate Professor, Department Medicine, Division of Cardiology
Adjunct appointment, Department of Biomedical Engineering

Industry Roles

Board member BioHeart Inc, Tampa Florida (2000-2001)
Co-Founder, Taylor Technologies/Miromatix Medical, Inc., Minneapolis, MN (2008)
Co-founder/CEO, Stem Cell Security, LLC, Houston, TX (2017)

Other Notable Professional Roles (selected)

Alliance for Regenerative Manufacturing Institute (ARMI) Leadership Advisory Council (2019-2020)
AABB Standards Committee member (2018-2019)
Texas Regenerative Medicine Summit. Scientific Panel, Austin, TX (2018)
Rice University Baker Institute for Public Policy. “Charlie’s Law: Increased Access to Stem Cell Interventions in Texa” (2017)
Texas Medical Center Regenerative Medicine Strategy Design Team, Co-chair (2014-

2016)

National Policy and Science Summit on Women’s Cardiovascular Health, Washington, DC Invited Participant, (2015)
Co-chair, Sex Bias in Cardiovascular Research Working Group, NIH National Heart, Lung, and Blood Institute (2014)
Alliance for Regenerative Medicine Board of Directors (2013-2016)
Alliance for Regenerative Medicine Executive Board (2013-2015)
S. Food and Drug Administration Cellular, Tissue and Gene Therapies Advisory
Committee, Center for Biologics Evaluation and Research (2005-2010)
NIH National Heart, Lung, and Blood Institute Biomedical Imaging Research Opportunities Workshop, Invited Participant, (2005)

Academic Productivity

Publications: >165 peer-review publications in scientific journals
Research support: Career total > $25M; PI or co-PI on >20 federal, state, and foundation grants as well as numerous academic, private, and corporate awards
Commercialization: 4 US Patent Awards, 9 US Patent Applications, 2 Provisional Patent Applications; 28 International Patents
Education: More than 30 MDs, PhDs, and MD/PhDs have completed predoctoral or postdoctoral research fellowships in D Taylor’s labs at Duke, UMN, or THI
Service to scientific community: over 300 international, national, regional and local keynote lectures and other scientific presentations

Fabrizio Gramuglio

Senior Advisor, ISMC Human Persona Robotics HCI and Augmented Interaction Group

Fabrizio is an innovative and creative entrepreneur, pioneering emerging technologies in the areas of artificial intelligence (AI), artificial empathy (AE) and Human-Computer Interactions (HCI). He has more than 15 years of experience in managing IT projects based in these areas, amassing solid experience at a senior management level with national and international private and public corporations, including partnerships and collaborations with scientific, academic and government organizations.

Fabrizio is CEO of Forever Identity, an Italian based company specialising in a unique field—the preservation of identity, memory and personality for interaction with future generations—and he will work in exclusive partnership with ISMC, to advance the development and state-of-the-art of an interactive, multi-sensorial and emotional 3-D Persona to assist space-travellers.

Fabrizio gained his first degree in Biological Sciences in 1997 from the University of Genoa, followed up by a Master’s degree in Digital Technologies and Net Economy in 2002 from the University of Ferrara, Italy. He is well respected within his field and has participated in numerous international forums, scientific and corporate seminars, and national and international congresses.

Peter Gladis

President Peter Gladis Consulting, LLC

Senior executive with large and small technology companies. Currently, President Peter Gladis Consulting, LLC (Clients: Biotech: Sonix Medical Devices, Molecular Surface Technologies, DICOM Director, Circulatech; Cybersecurity: TrustWrx and NewPush), and Director Marketing Strategies, STAR Associates, Inc. Standing Panel Member, National Science Foundation Small Business Innovation & Research (SBIR/STTR) and Partnerships for Innovation (PFI) Programs; DXC Technology (was Computer Sciences Corp.), Director Cybersecurity Market Development; RSL Fiber Systems and SpecTran Specialty Optics, Fiberoptic Technologies. Member: The International Space Medicine Consortium (ISMC), The Association of the U.S. Army (AUSA), and the International Chili Society. Expertise in technology commercialization/deployment, strategic planning, and marketing.

QUALIFICATIONS
Skill Categories
❖ Commercialization & Growth Strategies
❖ SBIR/STTR/PFI Small Business Consulting
❖ Market Strategies – Technology Deployment
❖ Private Equity Commercial Due Diligence
❖ Strategic Planning/Strategic Alliances
Market/Sector/Technology Expertise
❖ Cybersecurity/IT Networks/AI/ML
❖ Biomedical Devices, Software, Systems
❖ Photonics, Fiber Optics, Optical Systems
❖ Defense/Government Telecom/Datacom
❖ Industrial/Electromechanical Equipment
SIGNIFICANT ACCOMPLISHMENT EXAMPLES
❖ Peter Gladis Consulting, LLC: Assisted over 50 small companies in business planning, and in obtaining non-diluting technology development grants from the National Science Foundation (NSF) up to $2 million.
❖ STAR Associates, Inc.: Commercialization assessments; investment consulting of technology start-ups.
❖ International Space Medicine Consortium (ISMC): Member
❖ National Science Foundation: 11 years, 450 SBIR/STTR/PFI Proposals evaluated and funding recommendations.
❖ DXC Technology (was CSC) Global Cybersecurity: Led global organization that developed and introduced sophisticated Cybersecurity Managed Security Service (MSS): “Advanced Threat Detection.”
❖ RSL Fiber Systems/SpecTran Specialty Optics: High Performance Fiberoptic and optical systems.
❖ Ultra Electronics/DNE Technologies: Military Datacom; Strategic Alliances; DoD Programs with secure systems.
❖ General Electric Company: Led the fastest growing, highest margin unit in a $2B GE Strategic Business Unit.

EMPLOYMENT HISTORY
2015 – Present: President, Peter Gladis Consulting, LLC. SBIR/STTR/PFI consulting, multiple market business strategy development, investment consulting; technology commercialization.
2015 – Present: Director, Marketing Strategies – STAR Associates. Investment advisory/funding services.
2012 – 2015: CSC (now DXC) Global Cybersecurity, Director – Market Development and Sales Operations.
2010 – 2012: RSL Fiber Systems, Director Marketing & Sales. Worldwide responsibility for new market penetration
1997 – 2010: DNE/Ultra Electronics, Director – Marketing and Technical Support. Global marketing initiatives and technical support and training for military and commercial tactical datacom/telecom.
1994 – 1997: SpecTran Specialty Optics, Director – Sales & Market Development. Specialty fiberoptics.
1993 – 1994: Universal Voltronics, Director – Marketing & Sales. Global Sales and Marketing strategy.
1970 – 1993: General Electric. Various leadership marketing, sales, and business development positions.

EDUCATION
❖ BS Electrical Engineering, Villanova University 1970; major GE executive leadership development courses

James B. McCarthy, M.B.A., J.D.

Director - Corporate Due Diligence Management

Mr. McCarthy is based in Star Associates Chicago office where he addresses legal, organizational structure, development, and financial issues for Star clients and partners. His forty-five years’ experience in the healthcare, financial and bio-medical fields has ranged from financial analysis and project planning to senior management roles. His experience includes:

Developing, financing, and managing hospitals, ambulatory surgery centers, and diagnostic centers in the United States and overseas;
Developing, structuring, and implementing international healthcare joint venture arrangements; and
Serving on multiple public and private corporate boards in the banking, biodefense, space medicine, education, biomaterials, and stem cell fields.

From 1991 until 2016, he was Chairman and CEO of Gemini Consulting Group, Inc., an international healthcare consulting company. Previously, Mr. McCarthy was the Executive Vice President of a Chicago-based health care consulting company and has also held positions as Vice President and General Manager of a medical device manufacturing company in Chicago and spent five years in increasingly responsible planning positions with the Medical Products Division of 3M Company.

Mr. McCarthy received his B.A. from the University of Notre Dame, his J.D. from the Loyola University School of Law, and his M.B.A. from the Keller Graduate School of Management. He is a member of various state and national organizations, including the American Health Lawyers Association.

Mr. McCarthy is a founder and former member of the Board of Directors of CareSpan Health, Inc., Vancouver, BC. He also previously served on the Board of Directors of the International Space Medicine Consortium, Inc., Washington, D.C. and the Board of Trustees at the University of San Diego, San Diego, California. He is currently a Life Trustee at Lake Forest Academy, Lake Forest, Illinois, and also serving on the Board of CrossBraining, Inc. an EdTech company based in Ann Arbor, Michigan, and Organamet Bio, Inc., Houston, TX.

Mr. McCarthy also served for eleven years on the Board of Directors of Wintrust Financial Corporation (WTFC, Nasdaq) Rosement, Illinois, a $46 Billion financial holding company. He held other prior board positions at Hinsdale Bank and Trust Company, Hinsdale, Illinois, Protein Polymer Technologies, Inc. San Diego, California, JMAR Technologies, Inc. San Diego, California, StemCyte, Inc., Covina, California and Sirigen Group Ltd., London, England.

Forever Identity offers three distinct products to create and preserve your identity, biography, memory, personality, and physical aspects; and then, allowing interaction with future generations. We combine artificial intelligence, decision, ethic and moral engines, semantic and ontology experts to provide cutting-edge products. The company is developing applications to transform the media experience from 2 senses (audio and video) to all 5 senses.

WebInnovaSpace a Think Tank company developing global, inclusive, diverse and disruptive scientific projects and educational initiatives.

Provides corporate advisory services related to scientific, technology and engineering products and systems R&D and Contract Research Operations for: high voltage pulse power; linear/ synchrotron/colliding beam particle accelerators; ICF/MCF, ohmic heating and intercept impact fusion; EMP/Flash X-Ray, ECM, NPB, solid state pathogen/compound photo-luminescence inactivation/decomposition; medical diagnostic/therapeutic and applied AJ/AR/VR/XR ML and HMI fields of use.

Innovative Forensics Inc.

Using virtual and augmented reality, AI/Machine Learning, haptic and robotic technology, Innovative Forensics Inc (IFI) applies these needs through the development of forensic pathology Scene Training And Certification (DESTAC) platform applying our Interactive Virtual Forensic Pathologist (IVFP). The DESTAC platform offers online training/certification programs, where IVFP will offer smartphone accessible interactive SOP, and a Remote Pathology System, all of which will facilitate an interdisciplinary understanding and teaching of best practices, cutting horizontally across multiple discipline silos to deliver coordinated, efficient, and standardized death scene investigation, and a means for forensic pathology to be conducted remotely through robotic avatars.

Go to the depths of the ocean without actually going there, in the biggest, deepest pool in the world. Explore the far reaches of space here on Earth at the world’s first extreme environment training, research and development facility. The UK Blue Abyss centre establishes the foremost collaborative, extreme environment research, test, and training facility, including the world’s first complete commercial astronaut training centre.

Provides fully integrated, state-of-the-art facilities to enable clients to optimise their R&D, innovation, and operational procedures, to increase productivity, reduce costs, and minimise risk.

Enables clients to benefit from bespoke pre-operations training & preparation and hi-fidelity experiential programmes.

The Remediators Incorporated is recognized worldwide for our contribution in the development and commercialization of mycoremediation, which employs the use of fungi for the remediation of terrestrial and waterborne toxins.

JP Accelerator Works Inc.

JP Accelerator Works, Inc. is dedicated to providing the research and industrial communities, throughout the world, with inexpensive and effective linear accelerator technology. Our staff of scientists, engineers and technicians have many years of combined experience designing, building and servicing linear accelerators and related technology.

CoolSilicon® specializes in the design, development and integration of custom materials- and microfluidics-based, self-contained, in silicon cooling solutions for single- and stacked-die semiconductor devices.

Our Leadership

Founders/Executive Management

Barry Ressler

Dr. Steve Diamond

Dr. Gordon Roesler

Dr. Thais Russomano

THOMAS T. CHEN

Dr. Doris A. Taylor

Fabrizio Gramuglio

Peter Gladis

James B. McCarthy​

Affiliates

Driving technology for leading brands

Partner Companies

Partner Companies we work with

Innovative Forensics Inc.

JP Accelerator Works Inc.

strategic partners

Interplanetary Space Sciences LLC (IPSSCI): Advancing earth-based science and technology to support applications for 21st Century space exploration

technologies

news

Interactive Behavioral Health Psychologist Persona

Contact Us

© 2022 Interplanetary Space Sciences. All rights reserved.

Barry Ressler

Dr. Steve Diamond

Gordon Roesler

Autonomous Space Robots CEO of Robots in Space

Thais Russomano

Professor THAIS RUSSOMANO MD MSc PhD

Dr. Thomas Chen

Chief Scientist

Doris A. Taylor, PhD, FAHA, FACC, FESC

Director – Advanced Regenerative Medical Science

Fabrizio Gramuglio

Senior Advisor, ISMC Human Persona Robotics HCI and Augmented Interaction Group

Peter Gladis

President Peter Gladis Consulting, LLC

James B. McCarthy, M.B.A., J.D.

Director - Corporate Due Diligence Management

Innovative Forensics Inc.

JP Accelerator Works Inc.

James B. McCarthy